Ignite Creation Date:
2024-05-05 @ 12:04 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00235183
Status:
COMPLETED
Last Update Posted:
2014-02-17
First Post:
2005-10-06
Brief Title:
Plasma Transfusion in Liver Transplantation
Sponsor:
Etablissement Français du Sang
Organization:
Etablissement Français du Sang
Study Overview
Official Title:
Plasma Transfusion in Liver Transplantation a Randomized Double Blind Multicenter Trial of Methylene Blue SolventDetergent and Quarantined Plasma
Status:
COMPLETED
Status Verified Date:
2014-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of the study is to compare the clinical efficacy of three types of plasma secured on the viral level either by quarantine or by chemical treatment in patients undergoing liver transplantation
Detailed Description:
Three types of plasma are transfused in bleeding patients undergoing liver transplantation
quarantined plasma
methylene blue treated plasma
solventdetergent plasma The main purpose is to show that the volume of methylene blue treated plasma consumed intraoperatively is equivalent to that of the 2 other types of plasma
In addition the correction of coagulation abnormalities are studied
quarantined plasma
methylene blue treated plasma
solventdetergent plasma The main purpose is to show that the volume of methylene blue treated plasma consumed intraoperatively is equivalent to that of the 2 other types of plasma
In addition the correction of coagulation abnormalities are studied
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None